We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $303M
1-Year Est. Return 5.43%
This Fund
S&P 500
This Quarter Est. Return
+16.42%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
–
Cap. Flow
+$173M
Cap. Flow %
99.81%
Top 10 Hldgs %
45.79%
Holding
95
New
93
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNR
Core Natural Resources Inc
CNR
+$18.6M
2
STNG icon
Scorpio Tankers
STNG
+$14.8M
3
TDW icon
Tidewater
TDW
+$7.7M
4
NE icon
Noble Corp
NE
+$6.7M
5
DEN
Denbury Inc.
DEN
+$5.39M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Energy 54.86%
2 Healthcare 14.58%
3 Consumer Discretionary 7.29%
4 Communication Services 5.11%
5 Financials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VINC
76
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$317K 0.18%
+15,544
New +$293K
DTIL icon
77
Precision BioSciences
DTIL
$178M
$309K 0.18%
+8,657
New +$342K
ANIP icon
78
ANI Pharmaceuticals
ANIP
$1.86B
$306K 0.18%
+7,600
New +$285K
XPER icon
79
Xperi
XPER
$364M
$301K 0.17%
+35,000
New +$400K
SPRY icon
80
ARS Pharmaceuticals
SPRY
$579M
$296K 0.17%
+34,755
New +$226K
TRVI icon
81
Trevi Therapeutics
TRVI
$2.57B
$289K 0.17%
+149,958
New +$296K
OCUL icon
82
Ocular Therapeutix
OCUL
$1.83B
$288K 0.17%
+102,457
New +$339K
HOWL icon
83
Werewolf Therapeutics
HOWL
$22.4M
$264K 0.15%
+128,800
New +$337K
CGEM icon
84
Cullinan Oncology
CGEM
$1.06B
$249K 0.14%
+23,600
New +$287K
CRDL
85
Cardiol Therapeutics
CRDL
$133M
$225K 0.13%
+440,626
New +$269K
ALEC icon
86
Alector
ALEC
$169M
$219K 0.13%
+23,697
New +$207K
OVID icon
87
Ovid Therapeutics
OVID
$427M
$200K 0.12%
+107,491
New +$183K
AXDX
88
DELISTED
Accelerate Diagnostics
AXDX
$185K 0.11%
+26,263
New +$287K
ARQ icon
89
Arq
ARQ
$83.3M
$153K 0.09%
+63,015
New +$171K
ADEA icon
90
Adeia
ADEA
$2.55B
$142K 0.08%
+15,000
New +$153K
BMTX
91
DELISTED
BM Technologies, Inc.
BMTX
$131K 0.08%
+25,150
New +$161K
CNTA
92
DELISTED
Centessa Pharmaceuticals
CNTA
$131K 0.08%
+42,235
New +$157K
AP icon
93
Ampco-Pittsburgh
AP
$163M
$114K 0.07%
+45,293
New +$140K
GEL icon
94
Genesis Energy
GEL
$1.82B
$50.4K 0.03%
+140,000
New +$1.44M
PAA icon
95
Plains All American Pipeline
PAA
$17.6B
$2.36K ﹤0.01%
+58,940
New +$698K
1 2 3
4

Similar funds

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
ECAM
East Coast Asset Management Essex, Massachusetts $303M AUM 35.55% 1-Year Est. Return
BPH
Boundless Plain Holdings Hong Kong $304M AUM
BCC
Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return
BKA
Brick & Kyle Associates Newtown, Pennsylvania $303M AUM 26.39% 1-Year Est. Return
AFO
Arrowroot Family Office Marina Del Rey, California $302M AUM 14.21% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $302M AUM 15.12% 1-Year Est. Return
WAOTB
Wealth Advisors of Tampa Bay Tampa, Florida $302M AUM 26.95% 1-Year Est. Return

Tejara Capital's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Tejara Capital, which disclosed 95 positions worth $174M. Its ten largest holdings account for 46% of the portfolio.

Its largest position is Core Natural Resources Inc: 275,444 shares worth $17.9M.

By sector, the portfolio is most concentrated in Energy at 55% of assets, followed by Healthcare and Consumer Discretionary.

  • Tejara Capital's largest Q4 2022 buy was Core Natural Resources Inc: 275,444 shares worth $17.9M.
  • Tejara Capital's ten largest holdings make up 46% of its $174M portfolio in Q4 2022.
  • Tejara Capital disclosed 95 positions in Q4 2022, its first 13F filing on record.

Based on Tejara Capital's 13F filing for Q4 2022, filed 13 Feb 2023.